Two vacancies with TI Pharma

TI Pharma has two metabolomics related PhD vacancies:

Integrative Metabolic Production and Profiling as a Novel Strategy in Hit-to-Lead Selection

In modern drug discovery innovative, efficient and throughput-directed metabolic stability assessment and metabolic profiling, i.e. metabolite identification and active metabolite screening, is becoming of key-importance. In this TI Pharma project, a new consortium, of the Leiden-Amsterdam Center of Drug Research (LACDR) at the Vrije Universiteit (Amsterdam), the Institute of Molecules and Materials (IMM) at the Radboud Universiteit (Nijmegen) and Organon BioSciences (Oss) has been created to develop innovative and integrative strategies for metabolite production, metabolic stability assessment and metabolite profiling. The new strategies are based on integration of combinatorial biochemistry and biocatalysis with Cytochromes P450, high-information content LC-MS, high-efficient LC-NMR and structure identification software routines.

European User Meeting on Transnational Access: Research Infrastructure Centre

Wageningen NMR Centre and Bioqualys BV are delighted to invite to for the first User Meeting for the EU supported clients of the Transitional Access: Research Infrastructure Centre (RITA) project. The meeting will be on November 29 and 30, 2007 in Hotel, Congres en partycentrum De Wageningse Berg in Wageningen, the Netherlands.

The mini-symposium on Friday afternoon includes these presentations:

• Prof. Dr. John C. Lindon, Imperial College London: NMR computational chemistry, multivariate analysis and their application to medicine
• Dr. Peter Rinke, Technical Manager at SGF/IRMA: Quality assessment of fruit juices using NMR
• Dr. Jacques Vervoort, Wageningen University: NMR and MS - The Dream Team
• Dr. Hartmunt Schaefer, Bruker BioSpin: New tools for NMR based metabonomics
• Dr. Maarten Honing, Organon, Medicinal Chemistry: LC-MS-NMR: the ultimate tool or identifying unknowns?